Bluefin Capital Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Bluefin Capital Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-45,000	Closed	-$503K	–	555
2022 Q4	$503K	Buy	+45,000	New	+$436K	0.07%	143

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bluefin Capital Management's OYST Position: Q1 2023 in Review

Bluefin Capital Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 45,000 shares — an estimated $503K sold.

Bluefin Capital Management first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $503K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Bluefin Capital Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bluefin Capital Management sold 45,000 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $503K.
Bluefin Capital Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Bluefin Capital Management's Oyster Point Pharma, Inc. Common Stock position peaked at $503K in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.